A close look at the Progressive Agenda, China’s deteriorating welcome mat in DC and US Tech IPOs.
CIO Perspectives: Healthcare investment approaches and enterprise-level considerations
Michael Cembalest analyzes the performance of over 6,700 domestic and international active equity managers, and discusses the challenges they face outperforming at a time of markets distorted by quantitative easing.
An update from the front lines of the Trade War, with a focus on implications for investors
Themes from the quarterly Quantitative Beta Research Summit
The food fight between the President and the Fed Chair could result in too much easing, and the expansion of valuations beyond sustainable levels. The other food fight: leveraged loan issuers vs buyers. Issuers are winning this fight hands down due.
Michael shares his thoughts on the US China trade war, Mexico tariffs and the US immigration policy.
Michael discusses US-China trade war in context, the outlook for prescription drug price legislation, and an updated ideological scorecard for 2020 Presidential candidates.
It was another rollercoaster ride for equity markets but this time ending on a high note, with the S&P 500 Index delivering a thrilling 13.6% return in the first quarter, the best start to a year since 1998.
The Fed halted tightening and propelled equities to their fastest recovery ever following a bear market. This decision was made despite the lowest unemployment rate in 40 years. Does that make sense? Also, a possible deal with China.